The global “Drug Delivery Systems Market” is projected to reach USD 45.20 billion by 2027, exhibiting a CAGR of 6.8% during the forecast period. Increasing prevalence of multiple chronic conditions (MCCs) worldwide is expected to be the leading factor driving the growth of this market, finds Fortune Business Insights™ in its report, titled “Drug Delivery Systems Market Size, Share & Industry Analysis, By Type (Inhalation, Transdermal, Injectables and Others), By Device Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Regional Forecast, 2020-2027”.

MCCs refer to the existence of more than one chronic condition in an individual. According to a study published by the World Economic Forum (WEF), 33% of adults around the world suffer from a combination of MCCs such as cardiovascular disease with diabetes and depression or even cancer. Precision Drug Delivery Systems can play a crucial role in managing these conditions as they are able to administer drugs at the exact location of the disease. As incidence of chronic conditions rises, the demand for these systems is likely to spike in the coming years.

Major Drug Delivery Systems Market Key players covered in the report include:

  • Pfizer Inc.(U.S)
  • West Pharmaceutical Services, Inc.(U.S)
  • Medtronic (Ireland)
  • Baxter International Inc. (S)
  • BD (Becton, Dickinson and Company)(U.S)
  • Ypsomed (Switzerland)
  • Nemera (France)
  • Gerresheimer AG (Germany)
  • 3M (S)

Get Request a Sample Copy of the Drug Delivery Systems Report:

https://www.fortunebusinessinsights.com/enquiry/sample/drug-delivery-systems-market-103070

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Drug Delivery Systems Market Analysis 2021:

Regional Analysis

North America to Hold Dominant Lead in the Market; Europe to Follow Closely

Among regions, North America is expected to dominate this market share during the forecast period owing to the active adoption of advanced drug delivery systems, especially for care of the elderly populace. Besides this, increased funding for medical R&D activities is also feeding the growth of this market. In 2019, the market size in the region was at USD 10.65 billion.

In Europe, the top growth driver is the rising prevalence of chronic diseases, coupled with the presence of large pharmaceutical companies, especially in Ireland, UK, Germany, and France. The market in Asia-Pacific is expected to be fueled by the expanding patient pool in India and China and the spreading awareness of the advantages of Drug Delivery Systems in the region.

As per the report findings, the market value was at USD 26.08 billion in 2019. The report also offers the following information:

  • Comprehensive analysis of the impact of COVID-19 outbreak on the market;
  • Detailed assessment of the market trends, drivers, and restraints;
  • In-depth examination of the regional dynamics and competitive environment shaping the market; and
  • Careful study of all the possible market segments.

Competitive Landscape

Growing Investments in Innovation by Companies to Foster Healthy Competition

Commanding presence of large pharmaceutical and medical devices companies is emerging as the chief feature of competition in this market. These companies are making strategic investments in elevating their innovation capacities to bring out novel Drug Delivery Systems for patients and physicians.

Industry Developments:

December 2019: US-based Insulet Corporation released its flagship Omnipod DASH™ Insulin Management System in the Netherlands and the UK. The novel insulin delivery device is designed to provide insulin delivery non-stop for three days, removing the need for daily injections for diabetics. It also features a touchscreen for patients to manage their condition on their own.

February 2019: Finland-domiciled Orion Corporation collaborated with Propeller Health to integrate Orion’s Easyhaler® product line with Propeller’s digital therapeutics platform. The inhaler range from Orion is designed for patients suffering from COPD and asthma. The connection between the two will be enabled by a custom-built sensor which will be synched with a mobile app.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/drug-delivery-systems-market-103070

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • New Product Launch
    • Technological Advancements in the Drug Delivery Systems Market
    • Key Industry Developments – Mergers, Acquisitions, and Partnerships
  • Global Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Injectable
      • Inhalation
      • Transdermal
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Conventional
      • Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis, Insights and Forecast – By Geography
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa
  • North America Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Injectable
      • Inhalation
      • Transdermal
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Conventional
      • Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
      • Canada
  • Europe Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Injectable
      • Inhalation
      • Transdermal
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Conventional
      • Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis, Insights and Forecast – By Country/Sub-region
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • Rest of Europe
  • Asia Pacific Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Injectable
      • Inhalation
      • Transdermal
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Conventional
      • Advanced
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Analysis, Insights and Forecast  – By Country/Sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Cardiometabolic Disease Market

Cardiometabolic Disease Market Size

Cardiometabolic Disease Market Share

Cardiometabolic Disease Market Trends

Cardiometabolic Disease Market Growth

Diagnostic Antibodies Market Analysis

Diagnostic Antibodies Market Business Opportunities

Diagnostic Antibodies Market Key Players

Diagnostic Antibodies Market Demand

Diagnostic Antibodies Market Competitive Landscape

Leave a Reply

Your email address will not be published. Required fields are marked *